Safety of Aggressive Lipid Management-Reference-Cited by-同舟云学术

Safety of Aggressive Lipid Management

Published:2007-05 Issue:17 Volume:49 Page:1753-1762
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Davidson Michael H.,Robinson Jennifer G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference66 articles.

1. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

2. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

3. Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial;de Lemos;JAMA,2004

4. High-dose atorvastatin vs. usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial;Pedersen;JAMA,2005

5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report;Circulation,2002

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Neuropathy Mimic: Statin-Induced Myopathy Presenting as Guillain-Barré Syndrome;Cureus;2024-08-08

2. Studying harms of interventions with an equity lens in randomized trials;Trials;2024-06-21

3. Lipid-lowering therapies in patients undergoing percutaneous coronary intervention;Vessel Plus;2024-04-08

4. Lipid-lowering therapies in patients undergoing percutaneous coronary intervention;Vessel Plus;2024-04-08

5. Activation of AMPK pathway by low‑dose donafenib and atorvastatin combination improves high‑fat diet‑induced metabolic dysfunction‑associated steatotic liver disease;Molecular Medicine Reports;2024-01-29